Browsing Tag
fidanacogene elaparvovec
1 post
FDA approves Pfizer’s HYMPAVZI for breakthrough hemophilia treatment
In a major leap for hemophilia patients, Pfizer Inc. (NYSE: PFE) announced that the U.S. Food and Drug…
Business news, market intelligence, and global industry analysis.